Vascular and renal effects of vasopressin and its antagonists in conscious rats with chronic myocardial infarction; evidence for receptor shift

Author： Lankhuizen I.M. van Veghel R. Saxena P.R. Schoemaker R.G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.423, Iss.2, 2001-07, pp. : 195-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction

By Wada K.-i. Tahara A. Arai Y. Aoki M. Tomura Y. Tsukada J. Yatsu T.

European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. : 169-177

Elsevier

Access to resources Recommend Favorite

Renal vascular reactivity to vasopressin in rats with diabetes mellitus

By Loichot C. Anjuere J. Nisato D. De Jong W. Imbs J.-L. Barthelmebs M.

European Journal of Pharmacology, Vol. 431, Iss. 3, 2001-11 ,pp. : 321-329

Elsevier

Access to resources Recommend Favorite

Effects of the CCK A receptor antagonists SR 27897B and PD140548 on baroreflex function in conscious rats

By Bunting M.W. Beart P.M. Widdop R.E.

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 35-39

Elsevier

Access to resources Recommend Favorite

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D. DeWald T.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats

By Rahmouni K. Barthelmebs M. Grima M. Imbs J.L. De Jong W.

European Journal of Pharmacology, Vol. 385, Iss. 2, 1999-12 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite